参考文献/References:
［1］Pasteau 0,Degrais P:The radium treatment of cancer of the prostate.Arch Roentgen Ray,1914;28:396-410.
［2］Flocks RH,Kerr HD,Elkins HB,et al.Treatment of carcinoma of the prostate by interstitial radiation with radioactive gold(Au-198):a preliminary report.J Urol,1952,68:510-522.
［3］Whitmore WF Jr,Hilaris B,Grabstald H:Retropublic implantation of iodine-125 in the treatment of prostate cancer.J Urol,1972,108:918-920.
［4］Hilaris B,Whitmore WF Jr,Batata MA,et al.Radiation therapy and pelvic node dissection in the management of cancer of the prostate.Am JRoentgenol Rad Ther Nuc1 Med,1974,4:832-838.
［5］Sogani PC.Pelvic lymphadenoectomy:techniques and complications.In Hilaris BS,Batata,MA:"Brachytherapy oncology-advances in prostate and other cancers."New York:Memorial SloanKettering Cancer Center,1983,79-82.
［6］Fuks Z,Leibel SA,Wallner KE,et al.The effect of local control on metastatic dissemination in carcinoma of the prostate:long-termresults in patients treated with 125I implantation.Int J Radiat Oncol Bio Phys,1991,21:537-547.
［7］Puthawala AA,Syed AM,Tansey L.Temporary iridium 192 implant in the management of carcinoma of the prostate.Endocuriether Hyperthermia Oncol,1985,1:25-33.
［8］Martinez A,Edmundson GK,Cox RS,et al.Combination of external beamirradiation and multiple-site perineal applicator(MUPIT)for the treatment of locally advanced or recurrent prostatic,anorectal,and gynecological malignancies.Int J Radiat Oncol Biol Phys,1985,11:391-398.
［9］Holm HH,Juul N,Pedersen JF,et al.Transperineal 125-iodine seed implantation in prostate cancer guided by transrectal ultrasonography.J Urol,1983,130:283-286.
［10］Schellhammer PF,Witmore RB,Kuban DA,et al.Morbidity and mortality of local failure after definitive therapy for prostate cancer.J Urol,1989,141:567-571.
［11］Stone NN,Ramin SA,Wesson MF,et al.Laparoscopic lymph node dissection combined with real-time interactive transrectal ultrasound guided transperineal radioactive seed prostate.J Urol,1995,153:1555-1560.
［12］Bastacky SI,Walsh PC,Epstein JI.Relationship between perineural tumor invasion and radical prostatectomy capsular penetration in clinical stage B adenocarcinome of the prostate.Am J Surg Path,1993,17:336-341.
［13］Ackerman DA,Barry JM,Wicklund RA,et al.Analysis of risk factors associated with prostate cancer extension to the surgical margin and pelvic node metastasis at radical prostatectomy.J Urol,1993,150:1845-1850.
［14］Loch T,McNeal JE,Stamey TA.Interpretation of bilateral positive biopsies in prostate cancer.J Urol,1995,154:1078-1083.
［15］Nori D,Moni J.Current issues in techniques of prostate brachytherapy.Semi Surg Oncol,1997,13:444-453.
［16］Carlton CE,Jr,Scardino PT.Combination interstitial and external irradiation for prostatic cancer.Prog Clin Biol Res,1987,243B:141-169.
［17］Wallner K,Roy J,Harrison L.Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma.J Clin Oncol,1996,14:449-453.
［18］Blasko JC,Wallner K,Grimm PD,et al.Prostate specific antigen based disease control following ultrasound guided 125-iodine implantation for stage T1/T2 prostatic carcinoma.J Urol,1995,154:1096-1099.
［19］Osian AD,Nori D.Conformal brachytherapy of Carcinoma of the prostate.Endocuriether/Hypertherm Oncol,1994,10:15-24.
［20］Wallner K.Iodine-125 brachtherapy for early stage prostate cancer:new techniques may achieve bettert results.Oncology,1991,5:115-122.
［21］Yu Y,Waterman FW,Suntharalingam N,et al.Limitations of the minimum peripheral dose as a parameter for dose specification im permanent 125I prostate implants.Int J Radiat Oncol Biol Phys,1996,34:717-725.
［22］Wallner K,Roy J,Harrison L,et al.Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 brachtherapy.Int J Radiat Oncol Biol Phys,1995,32:465-471.